menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Advancements in mRNA Therapeutics for Autoimmune Diseases

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    New mRNA therapeutics are on the horizon for patients with autoimmune diseases. What kind of impact might these therapeutics have? To answer this question, Dr. Hyunjoon Kim, Assistant Professor in the Department of Pharmaceutical Chemistry at the University of Kansas, joins us to explore these new therapeutics.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    New mRNA therapeutics are on the horizon for patients with autoimmune diseases. What kind of impact might these therapeutics have? To answer this question, Dr. Hyunjoon Kim, Assistant Professor in the Department of Pharmaceutical Chemistry at the University of Kansas, joins us to explore these new therapeutics.

Facebook Comments

Schedule7 Dec 2022